维普中文期刊产品整合服务
17篇 您的检索式:作者名="Huining He"
    题名 作者 年代 出处 被引量
1Tat-functionalized Ag-Fe_3O_4 nano-composites as tissue-penetrating vehicles for tumor magnetic targeting and drug delivery显示文摘In this paper, we prepared a dual functional system based on dextrin-coated silver nanoparticles which were further attached with iron oxide nanoparticles and cell penetrating peptide(Tat), producing Tat-modified Ag-Fe_3O_4 nanocomposites(Tat-FeAgNPs). To load drugs, an –SH containing linker, 3-mercaptopropanohydrazide, was designed and synthesized. It enabled the silver carriers to load and release doxorubicin(Dox) in a pH-sensitive pattern. The delivery efficiency of this system was assessed in vitro using MCF-7 cells, and in vivo using null BalB/c mice bearing MCF-7 xenograft tumors. Our results demonstrated that both Tat and externally applied magnetic field could promote cellular uptake and consequently the cytotoxicity of doxorubicin-loaded nanoparticles,with the IC_(50) of Tat-FeAgNP-Dox to be 0.63 mmol/L. The in vivo delivery efficiency of Tat-FeAgNP carrying Cy5 to the mouse tumor was analyzed using the in vivo optical imaging tests, in which TatFeAgNP-Cy5 yielded the most efficient accumulation in the tumor(6.772.4% ID of Tat-FeAgNPs).Anti-tumor assessment also demonstrated that Tat-FeAgNP-Dox displayed the most significant tumor-inhibiting effects and reduced the specific growth rate of tumor by 29.6%(P ? 0.009), which could be attributed to its superior performance in tumor drug delivery in comparison with the control nanovehicles.Ergang Liu Meng Zhang Hui Cui Junbo Gong Yongzhuo Huang Jianxin Wang Yanna Cui Weibing Dong Lu Sun Huining He Victor C.Yang 2018Acta Pharmaceutica Sinica B2018,8,6:5
2Nose-to-brain delivery of macromolecules mediated by cell-penetrating peptides显示文摘Brain delivery of macromolecular therapeutics(e.g., proteins) remains an unsolved problem because of the formidable blood–brain barrier(BBB). Although a direct pathway of nose-to-brain transfer provides an answer to circumventing the BBB and has already been intensively investigated for brain delivery of small drugs,new challenges arise for intranasal delivery of proteins because of their larger size and hydrophilicity. In order to overcome the barriers and take advantage of available pathways(e.g., epithelial tight junctions, uptake by olfactory neurons, transport into brain tissues, and intra-brain diffusion), a low molecular weight protamine(LMWP) cell-penetrating peptide was utilized to facilitate nose-to-brain transport. Cell-penetrating peptides(CPP)have been widely used to mediate macromolecular delivery through many kinds of biobarriers. Our results show that conjugates of LMWP–proteins are able to effectively penetrate into the brain after intranasal administration.The CPP-based intranasal method highlights a promising solution for protein therapy of brain diseases.Tingting Lin Ergang Liu Huining He Meong Cheol Shin Cheol Moon Victor C.Yang Yongzhuo Huang 2016Acta Pharmaceutica Sinica B2016,6,4:4
3Overcoming oral insulin delivery barriers: application of cell penetrating peptide and silica-based nanoporous composites显示文摘Huining HE Junxiao YE Jianyong SHENG Jianxin WANG Yongzhuo HUANG Guanyi CHEN Jingkang WANG Victor C YANG 2013Frontiers of Chemical Science and Engineering2013,7,1:3
4Significance and strategies in developing delivery systems for bio-macromolecular drugs显示文摘Huining HE Qiuling LIANG Meong Cheoi SHIN Kyuri LEE Junbo GONG Junxiao YE Quan LIU Jingkang WANG Victor YANG 2013Frontiers of Chemical Science and Engineering2013,7,4:2
5Ultrasound-mediated targeted microbubbles: a new vehicle for cancer therapy显示文摘Junxiao YE Huining HE Junbo GONG Weibing DONG Yongzhuo HUANG Jianxin WANG Guanyi CHEN Victor C YANG 2013Frontiers of Chemical Science and Engineering2013,7,1:2
6Antitumor synergism between PAK4 silencing and immunogenic phototherapy of engineered extracellular vesicles显示文摘Immunotherapy has revolutionized the landscape of cancer treatment.However,single immunotherapy only works well in a small subset of patients.Combined immunotherapy with antitumor synergism holds considerable potential to boost the therapeutic outcome.Nevertheless,the synergistic,additive or antagonistic antitumor effects of combined immunotherapies have been rarely explored.Herein,we established a novel combined cancer treatment modality by synergizing p21-activated kinase 4(PAK4)silencing with immunogenic phototherapy in engineered extracellular vesicles(EVs)that were fabricated by coating M1 macrophage-derived EVs on the surface of the nano-complex cores assembled with si RNA against PAK4 and a photoactivatable polyethyleneimine.The engineered EVs induced potent PAK4 silencing and robust immunogenic phototherapy,thus contributing to effective antitumor effects in vitro and in vivo.Moreover,the antitumor synergism of the combined treatment was quantitatively determined by the Compu Syn method.The combination index(CI)and isobologram results confirmed that there was an antitumor synergism for the combined treatment.Furthermore,the dose reduction index(DRI)showed favorable dose reduction,revealing lower toxicity and higher biocompatibility of the engineered EVs.Collectively,the study presents a synergistically potentiated cancer treatment modality by combining PAK4 silencing with immunogenic phototherapy in engineered EVs,which is promising for boosting the therapeutic outcome of cancer immunotherapy.Mei Lu Haonan Xing Wanxuan Shao Pengfei Wu Yuchuan Fan Huining He Stefan Barth Aiping Zheng Xing-Jie Liang Yuanyu Huang 2023Acta Pharmaceutica Sinica B2023,13,9:1
7Biosafety materials:Ushering in a new era of infectious disease diagnosis and treatment with the CRISPR/Cas system显示文摘Despite multiple virus outbreaks over the past decade,including the devastating coronavirus disease 2019(COVID-19)pandemic,the lack of accurate and timely diagnosis and treatment technologies has wreaked havoc on global biosecurity.The clustered regularly interspaced short palindromic repeats(CRISPR)/CRISPR-associated proteins(Cas)system has the potential to address these critical needs for tackling infectious diseases to detect viral nucleic acids and inhibit viral replication.This review summarizes how the CRISPR/Cas system is being utilized for the treatment and diagnosis of infectious diseases with the help of biosafety materials and highlights the design principle and in vivo and in vitro efficacy of advanced biosafety materials used to deal with virus attacks.Yuquan Zhang Ziyue Li Julien Milon Essola Kun Ge Xuyan Dai Huining He Haihua Xiao Yuhua Weng Yuanyu Huang 2022Biosafety and Health2022,4,2:1
8Long acting carmustine loaded natural extracellular matrix hydrogel for inhibition of glioblastoma recurrence after tumor resection显示文摘Many scientific efforts have been made to penetrate the blood-brain barrier and target glioblastoma cells,but the outcomes have been limited.More attention should be given to local inhibition of recurrence after glioblastoma resection to meet real medical needs.A biodegradable wafer containing the chemotherapeutics carmustine(1,3-bis(2-chloroethyl)-1-nitrosourea,BCNU)was the only local drug delivery system approved for clinical glioblastoma treatment,but with a prolonged survival time of only two months and frequent side effects.In this study,to improve the sustained release and prolonged therapeutic effect of drugs for inhibiting tumor recurrence after tumor resection,both free BCNU and BCNU-poly(lactic-co-glycolic acid)(the ratio of lactic acid groups to glycolic acid groups is 75/25)nanoparticles were simultaneously loaded into natural extracellular matrix hydrogel from pigskin to prepare BCNU gels.The hydrogel was injected into the resection cavity of a glioblastoma tumor immediately after tumor removal in a fully characterized resection rat model.Free drugs were released instantly to kill the residual tumor cells,while drugs in nanoparticles were continuously released to achieve a continuous and effective inhibition of the residual tumor cells for 30 days.These combined actions effectively restricted tumor growth in rats.Thus,this strategy of local drug implantation and delivery may provide a reliable method to inhibit the recurrence of glioblastoma after tumor resection in vivo.Sunhui Chen Qiujun Qiu Dongdong Wang Dejun She Bo Yin Meihong Chai Huining He Dong Nyoung Heo Jianxin Wang 2022Frontiers of Chemical Science and Engineering2022,16,4:1
9Antimicrobial and Thermal-Responsive Layer-by-Layer Assembly Based on Ionic-Modified Guanidine Polymer and PVA显示文摘Yuanfeng Pan Huining Xiao Guanglei Zhao Beihai He 2008Polymer Bulletin2008,,5:1
10Improved method for synthesis of low molecular weight protamine–siRNA conjugate显示文摘RNAi technology has aroused wide public interest due to its high efficiency and specificity to treat multiple types of diseases. However, the effective delivery of siRNA remains a challenge due to its large molecular weight and strong anionic charge. Considering their remarkable functions in vivo and features that are often desired in drug delivery carriers, biomimetic systems for siRNA delivery become an effective and promising strategy. Based on this, covalent attachment of synthetic cell penetrating peptides(CPP) to siRNA has become of great interest. We developed a monomeric covalent conjugate of low molecular weight protamine(LMWP, a well-established CPP) and siRNA via a cytosol-cleavable disulfide linkage using PEG as a crosslinker. Results showed that the conjugates didn't generate coagulation, and exhibited much better RNAi potency and intracellular delivery compared with the conventional charge-complexed CPP/siRNA aggregates. Three different synthetic and purification methods were compared in order to optimize synthesis efficiency and product yield. The methodology using hetero-bifunctional NHS–PEG–OPSS as a crosslinker to synthesize LMWP–siRNA simplified the synthesis and purification process and produced the highest yield. These results pave the way towards siRNA biomimetic delivery and future clinical translation.Zhili Yu Junxiao Ye Xing Pei Lu Sun Ergang Liu Jianxin Wang Yongzhuo Huang Seung Jin Lee Huining He 2018Acta Pharmaceutica Sinica B2018,8,1:1
11Developing macromolecular therapeutics:the future drug-of-choice显示文摘Macromolecular drugs including peptides,proteins,antibodies,polysaccharides and nucleic acids have been widely used for therapy of major diseases such as carcinoma and AIDS as well as cardiovascular and neurodegenerative disorders among other medical conditions.Due to their unmatched properties of high selectivity and efficiency,macromolecular drugs have been recognized as the drug-of-choice of the future.Since worldwide progress on macromolecular therapeutics still remains in the infant stage and is therefore wide open for equalground competition,R&D related to macromolecular drugs should be considered as the main point of focus in China in setting up its strategic plans in pharmaceutical development.In this article,research strategies and drug delivery approaches that should be adopted to enhance the therapeutic effects of macromolecular drugs are reviewed.In addition,comments concerning how to implement such strategies to excel from competition in this challenging research field,such as the design of innovative and highly effective delivery systems of macromolecular drugs with self-owned intellectual property rights,are provided.Huining HE Weibing DONG Junbo GONG Jingkang WANG Victor C.YANG 2010Frontiers of Chemical Science and Engineering2010,4,1:0
12Immobilization of penicillin G acylase onto amino-modified silica hydrogel显示文摘Amino-modified silica hydrogel(N-MSHG)was prepared by a simple sol-gel processing via the cocondensation of commercial silica sol with 3-aminopropyltrieoxysilane.Penicillin G acylase(PGA),a model enzyme,was covalently immobilized onto the N-MSHG and then was used for the enzymatic synthesis of amoxicillin.The samples were characterized by Nitrogen sorption analysis,FT-IR and thermal gravimetric analysis(TGA).The results showed that the amino-modified gel was a mesoporous material with an average pore size of 12.64±0.17 nm.The immobilization process was efficient and the immobilized enzyme showed high catalytic efficiency.The yield of the synthesis of amoxicillin in aqueous media was 38%for 2.5 h.This sol-gel preparation is simple and shows prominent potential value in industrial processing.Weibing DONG Huining HE Junbo GONG Victor CYANG 2010Frontiers of Chemical Science and Engineering2010,4,1:0
13An injectable signal-amplifying device elicits a specific immune response against malignant glioblastoma显示文摘Despite exciting achievements with some malignancies,immunotherapy for hypoimmunogenic cancers,especially glioblastoma(GBM),remains a formidable clinical challenge.Poor immunogenicity and deficient immune infiltrates are two major limitations to an effective cancer-specific immune response.Herein,we propose that an injectable signal-amplifying nanocomposite/hydrogel system consisting of granulocyte-macrophage colony-stimulating factor and imiquimod-loaded antigen-capturing nanoparticles can simultaneously amplify the chemotactic signal of antigen-presenting cells and the'danger'signal of GBM.We demonstrated the feasibility of this strategy in two scenarios of GBM.In the first scenario,we showed that this simultaneous amplification system,in conjunction with local chemotherapy,enhanced both the immunogenicity and immune infiltrates in a recurrent GBM model;thus,ultimately making a cold GBM hot and suppressing postoperative relapse.Encouraged by excellent efficacy,we further exploited this signal-amplifying system to improve the efficiency of vaccine lysate in the treatment of refractory multiple GBM,a disease with limited clinical treatment options.In general,this biomaterial-based immune signal amplification system represents a unique approach to restore GBM-specific immunity and may provide a beneficial preliminary treatment for other clinically refractorymalignancies.Qiujun Qiu Sunhui Chen Huining He Jixiang Chen Xinyi Ding Dongdong Wang Jiangang Yang Pengcheng Guo Yang Li Jisu Kim Jianyong Sheng Chao Gao Bo Yin Shihao Zheng Jianxin Wang 2023Acta Pharmaceutica Sinica B2023,13,12:0
14First International Symposium on Nanocellulosic Materials,Hangzhou,China:Spurring Research and Innovation in Nanocellulosic Materials by Bringing Creative Minds Together显示文摘From May 20 to May 21,2017,the 1st International Symposium on Nanocellulosic Materials,hosted by China Technical Association of Paper Industry(CTAPI)and its affiliated Nanocellulose and Materials Committee,was held in Hangzhou,China.This timely symposium attracted about 270 attendees from 8 countries,bringing creative minds together for facilitating more breakthroughs in research,innovation,and commercialization.Jing Shen Zhibin He Huining Xiao 2017Journal of Bioresources and Bioproducts2017,2,3:0
15About the Journal of Bioresources and Bioproducts (JBB)显示文摘The Journal of Bioresources and Bioproducts(JBB)is devoted to publish high-quality peer-reviewed technical research articles on the science and technology related to bio-resources and bio-products.As the petroleum-based economy will be phasing out in a foreseeable period of time,the industrial and scientific societies are paying much attention to the renewable and sustainable resources:bioresources.Zhibin He Jianshu Li Huining Xiao 2016Journal of Bioresources and Bioproducts2016,1,1:0
16Curcumin based combination therapy for anti-breast cancer: from in vitro drug screening to in vivo efficacy evaluation显示文摘当药抵抗看起来是在 monotherapy 的越来越多的 anticancer 药的一个不可避免的问题时,联合药治疗成为了一个繁荣的方法减少管理的全部的药剂量以及克服癌房间的药抵抗。Curcumin,考虑了作为 chemoresistance 的一块压板根据它的多重反肿瘤的机制在癌症治疗拥有 multifaceted 角色,能显著地便于它的反癌症功能并且改进经由联合用法与的治疗学的效果许多有不同反应机制的另外的药。探索这可能性,四反癌症都拥有药抵抗问题的某个度的化学疗法的代理人,包括三个酷氨酸 kinase 禁止者( erlotinib , sunitinib 和 sorafenib ),那对不同房间小径和典型 anticancer 药 doxorubicin 正在起作用,个别地与 curcumin 被相结合在 vitro 并且在 vivo 检验 synergistic 反肿瘤效果。结果表明在 0.46 的臼齿的比率与 curcumin 相结合的 sunitinib 在 vitro 产出大多数有势力 synergistic 效果,并且因此为进一步的动物评估被选择。为了推进,提高 anticancer 效果,牛的浆液白朊(BSA ) nanoparticles 作为一个搬运人被利用在 situ 交付选择的药联合。在证实的 vivo 调查结果初步我们能由我们的途径在测试动物为延长时间时期维持类似的注射的药比率的假设,从而最大化还最小化这些药的毒性的治疗学的力量。这个工作能在联合药治疗和实现上开创一条新大街如此的药的临床的用途。Sunhui Chen Qiuling Liang Shuping Xie Ergang Liu Zhili Yu Lu Sun Meong Cheol Shin Seung Jin Lee Huining He Victor C. Yang 2016Frontiers of Chemical Science and Engineering2016,10,3:0
17Environment-tolerant ionic hydrogel-elastomer hybrids with robust interfaces,high transparence,and biocompatibility for a mechanical-thermal multimode sensor显示文摘The human skin,an important sensory organ,responds sensitively to external stimuli under various harsh conditions.However,the simultaneous achievement of mechanical/thermal sensitivity and extreme environmental tolerance remains an enormous challenge for skin-like hydrogel-based sensors.In this study,a novel skin-inspired hydrogel–elastomer hybrid with a sandwich structure and strong interfacial bonding for mechanical–thermal multimode sensing applications is developed.An inner-layered ionic hydrogel with a semiinterpenetrating network is prepared using sodium carboxymethyl cellulose(CMC)as a nanofiller,lithium chloride(LiCl)as an ionic transport conductor,and polyacrylamide(PAM)as a polymer matrix.The outer-layered polydimethylsiloxane(PDMS)elastomers fully encapsulating the hydrogel endow the hybrids with improved mechanical properties,intrinsic waterproofness,and long-term water retention(>98%).The silane modification of the hydrogels and elastomers imparts the hybrids with enhanced interfacial bonding strength and integrity.The hybrids exhibit a high transmittance(~91.2%),fatigue resistance,and biocompatibility.The multifunctional sensors assembled from the hybrids realize real-time temperature(temperature coefficient of resistance,approximately1.1%℃^(-1))responsiveness,wide-range strain sensing capability(gauge factor,~3.8)over a wide temperature range(from-20℃ to 60℃),and underwater information transmission.Notably,the dualparameter sensor can recognize the superimposed signals of temperature and strain.The designed prototype sensor arrays can detect the magnitude and spatial distribution of forces and temperatures.The comprehensive performance of the sensor prepared via a facile method is superior to that of most similar sensors previously reported.Finally,this study develops a new material platform for monitoring human health in extreme environments.Ya Lu Yiying Yue Qinqin Ding Changtong Mei Xinwu Xu Shaohua Jiang Shuijian He Qinglin Wu Huining Xiao Jingquan Han 2023InfoMat2023,5,4:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费